Evaluating hip precautions after hip replacement surgery
Are Postoperative Hip Precautions Necessary After a Total Hip Arthroplasty Via the Posterior Approach: A Prospective Randomized Trial
NA · Rush University Medical Center · NCT02686528
This study tests if following specific movement rules after hip replacement surgery helps prevent dislocations and improves recovery and satisfaction for patients.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Rush University Medical Center (other) |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT02686528 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of postoperative hip precautions on dislocation rates following total hip arthroplasty via the posterior approach. It aims to determine whether these precautions, which limit hip movement for six weeks post-surgery, influence patient recovery, daily activities, and satisfaction. The study will also assess the cost-effectiveness of implementing these precautions in clinical practice.
Who should consider this trial
Good fit: Ideal candidates are patients undergoing primary total hip arthroplasty via the posterior approach for noninflammatory arthritis.
Not a fit: Patients with a history of previous surgeries on the affected joint or those who cannot comply with study procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery protocols for patients undergoing hip replacement surgery, enhancing their overall satisfaction and reducing dislocation rates.
How similar studies have performed: While the necessity of hip precautions has been debated, this specific approach to evaluating their impact is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing a primary total hip arthroplasty via the posterior approach by participating attending surgeons at this institution * Index diagnosis of noninflammatory arthritis * Patients must be able to understand and comply with study procedures Exclusion Criteria: * Allergy or intolerance to the study materials * History of previous surgeries on the affected joint other than arthroscopy; i.e. revision THA or open surgeries
Where this trial is running
Chicago, Illinois
- Rush University Medical Center — Chicago, Illinois, United States (RECRUITING)
Study contacts
- Principal investigator: Omar Behery, MD — Orthopedics Surgeon
- Study coordinator: Anne DeBenedetti, MSc
- Email: anne.debenedetti@rushortho.com
- Phone: 3124322468
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Osteoarthritis, Degenerative Joint Disease, total hip arthroplasty, hip precautions, posterior approach